Linda Fredriksson
About me
DEGREES
2006
Doctor of Philosophy (PhD), Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden
Thesis title: Proteolytic activation and biological functions of the novel PDGFs
URL: http://hdl.handle.net/10616/43509
Main supervisor: Ulf Eriksson, co-supervisor: Ralf Pettersson2000
Master of Science (MSc) in Molecular Biology, University of Umeå, Sweden. Including 1-year ERASMUS exchange at University of London, King’s College, UK 1996 – 1997 and Master Thesis Diploma Work, AstraZeneca R&D, Södertälje, Sweden, 1998.
CURRENT POSITION
2017– Researcher, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
PREVIOUS POSITIONS
2012–2017
Assistant Professor, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
2011
Postdoctoral Researcher, Betsholtz Lab, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
2008-2010
Postdoctoral Researcher, Lawrence Lab, Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan Medical School, Ann Arbor MI, USA. Nov 2008 – Dec 2010.
2006-2008
Researcher, Ludwig Institute for Cancer Research Stockholm Branch, Stockholm, Sweden. Mar 2006 – Oct 2008.
2000-2006
PhD candidate, Ludwig Institute for Cancer Research Stockholm Branch, Stockholm, Sweden. Dec 2000 – Feb 2006.
1998-2000
Research scientist, AstraZeneca R&D, Södertälje, Sweden, Mar 1998 – Nov 2000.
Research
Our research focuses on understanding the cellular and molecular signaling events occurring in the neurovascular unit (NVU) in ischemic stroke. We hypothesize that cerebrovascular remodeling and changes in blood brain barrier (BBB) integrity contributes to disease progression. We propose that targeting biological processes in the NVU, and ultimately restoring BBB integrity, has the potential to significantly improve outcome of disease and co-ordinate the injury-induced fibrotic response.
The long-term goal of our research is to identify novel targets in the cerebrovasculature that can be translated into clinical practice to improve treatment options of ischemic stroke.
To achieve our goal, we use experimental in vivo models of disease, primarily a photothrombotic model of ischemic stroke and 2P intravital imaging through a chronic cortical window, as well as unique blocking agents and genetic tools.
Articles
- Article: JOURNAL OF CLINICAL INVESTIGATION. 2025;135(5):e171077Protzmann J; Zeitelhofer M; Stefanitsch C; Torrente D; Adzemovic MZ; Matjunins K; Randel SJI; Lewandowski SA; Muhl L; Eriksson U; Nilsson I; Su EJ; Lawrence DA; Fredriksson L
- Article: BIORXIV. 2024;:2024.10.11.617532Nilsson I; Su EJ; Fredriksson L; Sahlgren BH; Bagoly Z; Moessinger C; Stefanitsch C; Ning FC; Zeitelhofer M; Muhl L; Lawrence A-LE; Scotney PD; Lu L; Samén E; Ho H; Keep RF; Medcalf RL; Lawrence DA; Eriksson U
- Article: FLUIDS AND BARRIERS OF THE CNS. 2024;21(1):35Protzmann J; Jung F; Jakobsson L; Fredriksson L
- Article: EMBO MOLECULAR MEDICINE. 2022;14(12):e15809Hankeova S; Van Hul N; Laznovsky J; Verboven E; Mangold K; Hensens N; Adori C; Verhoef E; Zikmund T; Dawit F; Kavkova M; Salplachta J; Sjoqvist M; Johansson BR; Hassan MG; Fredriksson L; Baumgartel K; Bryja V; Lendahl U; Jheon A; Alten F; Fahnehjelm KT; Fischler B; Kaiser J; Andersson ER
- Article: TRANSLATIONAL STROKE RESEARCH. 2022;13(5):801-815Compartmentalized Actions of the Plasminogen Activator Inhibitors, PAI-1 and Nsp, in Ischemic StrokeTorrente D; Su EJ; Fredriksson L; Warnock M; Bushart D; Mann KM; Emal CD; Lawrence DA
- Article: BLOOD. 2022;140(4):388-400Goncalves A; Su EJ; Muthusamy A; Zeitelhofer M; Torrente D; Nilsson I; Protzmann J; Fredriksson L; Eriksson U; Antonetti DA; Lawrence DA
- Article: SCIENTIFIC REPORTS. 2020;10(1):22383Zeitelhofer M; Adzemovic MZ; Moessinger C; Stefanitsch C; Strell C; Muhl L; Brundin L; Fredriksson L; Olsson T; Eriksson U; Nilsson I
- Article: ACTA NEUROPATHOLOGICA. 2017;134(4):585-604Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic strokeSu EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun Y-Y; Yepes M; Kuan C-Y; Eriksson U; Strickland DK; Lawrence DA; Zhang L
- Article: SEMINARS IN THROMBOSIS AND HEMOSTASIS. 2017;43(2):154-168Fredriksson L; Lawrence DA; Medcalf RL
- Article: JOURNAL OF INTERNAL MEDICINE. 2017;281(3):273-283Wahlgren N; Thoren M; Hojeberg B; Kall T-B; Laska A-C; Sjostrand C; Hoijer J; Almqvist H; Holmin S; Lilja A; Fredriksson L; Lawrence D; Eriksson U; Ahmed N
- Article: BIOLOGY OPEN. 2016;5(4):461-474Andrae J; Gouveia L; Gallini R; He L; Fredriksson L; Nilsson I; Johansson BR; Eriksson U; Betsholtz C
- Article: ACTA NEUROPATHOLOGICA. 2016;131(3):453-464Lewandowski SA; Nilsson I; Fredriksson L; Lonnerberg P; Muhl L; Zeitelhofer M; Adzemovic MZ; Nichterwitz S; Lawrence DA; Hedlund E; Eriksson U
- Article: FRONTIERS IN CELLULAR NEUROSCIENCE. 2015;9:456Stefanitsch C; Lawrence A-LE; Olverling A; Nilsson I; Fredriksson L
- Article: FRONTIERS IN CELLULAR NEUROSCIENCE. 2015;9:385Su EJ; Fredriksson L; Kanzawa M; Moore S; Folestad E; Stevenson TK; Nilsson I; Sashindranath M; Schielke GP; Warnock M; Ragsdale M; Mann K; Lawrence A-LE; Medcalf RL; Eriksson U; Murphy GG; Lawrence DA
- Article: ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY. 2015;2(7):722-738Fredriksson L; Stevenson TK; Su EJ; Ragsdale M; Moore S; Craciun S; Schielke GP; Murphy GG; Lawrence DA
- Article: AMERICAN JOURNAL OF PATHOLOGY. 2012;180(3):1136-1144Fredriksson L; Nilsson I; Su EJ; Andrae J; Ding H; Betsholtz C; Eriksson U; Lawrence DA
- Article: ONCOGENE. 2009;28(4):534-544Ehnman M; Li H; Fredriksson L; Pietras K; Eriksson U
- Article: CANCER RESEARCH. 2009;69(1):369-378Anderberg C; Li H; Fredriksson L; Andrae J; Betsholtz C; Li X; Eriksson U; Pietras K
- Article: NATURE MEDICINE. 2008;14(7):731-737Su EJ; Fredriksson L; Geyer M; Folestad E; Cale J; Andrae J; Gao Y; Pietras K; Mann K; Yepes M; Strickland DK; Betsholtz C; Eriksson U; Lawrence DA
- Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2008;19(2):281-289Eitner F; Buecher E; van Roeyen C; Kunter U; Rong S; Seikrit C; Villa L; Boor P; Fredriksson L; Bakstrom G; Eriksson U; Ostman A; Floege J; Ostendorf T
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2005;280(29):26856-26862Fredriksson L; Ehnman M; Fieber C; Eriksson U
- Article: EMBO JOURNAL. 2004;23(19):3793-3802Fredriksson L; Li H; Fieber C; Li X; Eriksson U
- Article: ONCOGENE. 2003;22(10):1501-1510Li H; Fredriksson L; Li X; Eriksson U
- Show more
All other publications
- Preprint: BIORXIV. 2021Zeitelhofer M; Stefanitsch C; Protzmann J; Torrente D; Adzemovic MZ; Lewandowski SA; Muhl L; Eriksson U; Nilsson I; Su EJ; Lawrence DA; Fredriksson L
- Preprint: BIORXIV. 2021Hankeova S; Van Hul N; Laznovsky J; Mangold K; Hensens N; Verhoef E; Zikmund T; Dawit F; Kavkova M; Salplachta J; Sjöqvist M; Johansson B; Hassan M; Fredriksson L; Bryja V; Lendahl U; Jheon A; Alten F; Fahnehjelm KT; Fischler B; Kaiser J; Andersson E
- Conference publication: INTERNATIONAL JOURNAL OF STROKE. 2020;15(1_SUPPL):624-625Zeitelhofer M; Stefanitsch C; Adzemovic M; Sue J; Lewandowski S; Muhl L; Nilsson I; Lawrence D; Fredriksson L
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:930Zeitelhofer M; Adzemovic MZ; Huang J; Stefanitsch C; Mossinger C; Hochmeister S; Strell C; Muhl L; Lassmann H; Kockum I; Fredriksson L; Olsson T; Nilsson I; Eriksson U
- Review: PHARMACOLOGY & THERAPEUTICS. 2016;167:108-119Lewandowski SA; Fredriksson L; Lawrence DA; Eriksson U
- Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2016;36:150-151Su EJ; Fredriksson L; Warnock M; Bushart D; Lawrence DA
- Published conference paper: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2009;7(Suppl 1):155-158Su EJ; Fredriksson L; Schielke GP; Eriksson U; Lawrence DA
- Doctoral thesis: 2006Fredriksson L
- Review: CYTOKINE & GROWTH FACTOR REVIEWS. 2004;15(4):197-204Fredriksson L; Li H; Eriksson U
Grants
- Swedish Research Council1 January 2017 - 31 December 2017
- Swedish Research Council1 January 2013 - 31 December 2015
- Identification of new treatment options for neuropathology - implementation of a murine stroke modelVINNOVA1 December 2011 - 31 December 2016
- Swedish Research Council1 January 2011 - 31 December 2011
Employments
- Researcher, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 2017-
Degrees and Education
- Doctor Of Philosophy, Department of Cell and Molecular Biology, Karolinska Institutet, 2006